The following information has been compiled from publicly available Sources,
StratCom does not assume any responsibility for the accuracy or the authenticity
of the information and StratCom cannot be held liable for errors.
Scientists at Ciblex Corporation have discovered a protein, fibroblast growth factor 2, that permits a protein to exit cancer cells and stimulate blood vessel and tumor growth. The company expects that blocking protein export may offer a new approach to combat cancer and other diseases.
Researchers at the University of Ulm, Germany have reported that measurement of Interleukin-6 (IL-6), an immune system protein may help doctors judge the severity of injuries in trauma patients. IL-6 is produced by the body in response to injury, burns, and trauma caused by surgery.
Source: Archives of Surgery, March 2000.
![[Page Banner Image]](images/hnews.gif){kind=small}
![[HRule Image]](images/div.jpg){kind=small}
